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Abstract
The purpose of this study was to assess outcome measures and cost-effectiveness of robotic colorectal resections in adult 
patients with inflammatory bowel disease. The Cochrane Library, PubMed/Medline and Embase databases were reviewed, 
using the text “robotic(s)” AND (“inflammatory bowel disease” OR “Crohn’s” OR “Ulcerative Colitis”). Two investigators 
screened abstracts for eligibility. All English language full-text articles were reviewed for specified outcomes. Data were pre-
sented in a summarised and aggregate form, since the lack of higher-level evidence studies precluded meta-analysis. Primary 
outcomes included mortality and postoperative complications. Secondary outcomes included readmission rate, length of stay, 
conversion rate, procedure time, estimated blood loss and functional outcome. The tertiary outcome was cost-effectiveness. 
Eight studies (3 case-matched observational studies, 4 case series and 1 case report) met the inclusion criteria. There was no 
reported mortality. Overall, complications occurred in 81 patients (54%) including 30 (20%) Clavien-Dindo III–IV complica-
tions. Mean length of stay was 8.6 days. Eleven cases (7.3%) were converted to open. The mean robotic operating time was 
99 min out of a mean total operating time of 298.6 min. Thirty-two patients (24.7%) were readmitted. Functional outcomes 
were comparable among robotic, laparoscopic and open approaches. Case-matched observational studies comparing robotic 
to laparoscopic surgery revealed a significantly longer procedure time; however, conversion, complication, length of stay 
and readmission rates were similar. The case-matched observational study comparing robotic to open surgery also revealed 
a longer procedure time and a higher readmission rate; postoperative complication rates and length of stay were similar. No 
studies compared cost-effectiveness between robotic and traditional approaches. Although robotic resections for inflamma-
tory bowel disease are technically feasible, outcomes must be interpreted with caution due to low-quality studies.
Keywords Inflammatory bowel disease · Colorectal resection · Robotic surgical procedures
Introduction
Laparoscopic colorectal resections are now routinely per-
formed worldwide for patients with inflammatory bowel 
disease (IBD). Laparoscopy may be associated with less 
pain, reduced intra-abdominal adhesions, shorter duration 
of hospitalisation and quicker return to function compared 
to open surgery [1–3]. However, potential disadvantages 
include amplification of hand tremors and loss of wrist 
movement due to limited movement of the long instru-
ments within the trocars [4]. Consequently, robotic plat-
forms, such as the da  Vinci® system, have been devel-
oped in order to address these limitations. The theoretical 
advantages of these systems include a stable camera 
platform, three-dimensional image, excellent ergonomic 
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function with ambidextrous capability and freedom of 
movement in multiple directions [5].
The first robotic colorectal procedure was performed 
in New Jersey, USA, in 2001 [6], and this approach has 
gained considerable support over the past 15 years, espe-
cially for pelvic surgery. Early studies demonstrated that 
robotic total mesorectal excision (TME) for rectal can-
cer was safe and feasible and achieved a low number of 
positive resection margins and low conversion rates [7, 8]. 
Indeed, early results from the first international, multi-cen-
tre randomised controlled trial of 471 patients comparing 
robotic with laparoscopic TME revealed similar oncologi-
cal clearance, patient outcomes and conversion to open 
surgery rates [9]. Additionally, it has been proposed that 
it may reduce the risk of complications related to pelvic 
nerve injuries [10]. However, the advantages with respect 
to abdominal resections is less clear, as a randomised con-
trolled study did not report any benefits associated with 
the use of robotic assistance compared with laparoscopic 
right hemicolectomy [11]. Furthermore, the expense of 
installing and maintaining these platforms is significant 
and potentially prohibits their widespread use, particularly 
in an environment of limited health care resources. For 
instance, a recent American study comparing robotic to 
laparoscopic colectomies found a mean cost increase of 
approximately $15,595 per case [12].
Evidence to justify the use of robotic colorectal resection 
in patients with IBD remains even sparser. Therefore, the 
aim of this study was to perform a systematic review of the 
published literature in order to report the clinical outcomes 
and cost associated with robotic colorectal resections for 
patients with IBD.
Materials and methods
Search strategy
PubMed (1966–September 2016), Medline (1946–Septem-
ber 2016), the Cochrane Library and Embase (1947–Septem-
ber 2016) were electronically searched using the following 
text: “robotic(s)” AND (“inflammatory bowel disease” OR 
“Crohn’s” OR “ulcerative colitis”). In addition, reference 
lists of relevant articles, reviews and commentaries were 
manually searched, and experts in the specialty were con-
tacted to identify papers not captured by electronic searches 
(Fig. 1). Studies searched were limited to those performed 
in adult humans and published in the English language. Fur-
thermore, if the abstract or full manuscript was irrelevant 
or contained insufficient data (such as absence of subgroup 
analysis), it was excluded from the analysis.
Study quality assessment
Quality assessment was performed using the National Insti-
tute for Health and Care Excellence (NICE), Quality Assess-
ment for Case Series (QACS) tool [13] by scoring the stud-
ies out of a maximum of 8 points. A study scored 1 point 
each if; (a) it was multi-centre, (b) hypothesis/aim/objective 
clearly reported, (c) outcomes defined, (d) inclusion and 
exclusion criteria stated, (e) data prospectively collected, (f) 
patients consecutively recruited and (g) the main findings of 
the study are clearly described and (h) outcomes stratified.
Study outcomes
The primary outcome measures of interest included mortal-
ity and postoperative complications, classified according to 
Clavien-Dindo grade I–IV [14]. Secondary outcome meas-
ures included: (i) readmission rates (ii) length of postopera-
tive stay (LOS), (iii) conversion to open surgery rate, (iv) 
mean operating time, (v) estimated blood loss, (vi) func-
tional outcomes. The tertiary outcome measure was cost-
effectiveness, by comparing the cost of robotic procedures 
to its laparoscopic equivalent.
Data extraction
Quantitative data were extracted by 2 independent reviewers 
(SR/AH), and results were cross-checked. Any discrepancies 
in results were resolved by repeat data extraction, discussion 
and further review of the index study.
Data analysis
Given that the majority of studies lacked a control group, meta-
analysis of the data was precluded. As such, the results from 
each study are presented in a summarised and aggregate form.
Results
Search results
The Preferred Reporting Items for Systematic reviews and 
Meta-Analyses (PRISMA) guidelines [15] were adhered to 
for the reporting of this systematic review. The electronic 
search yielded a total of 60 citations. Following examina-
tion of the full-text manuscript (n = 43), a final total of 8 
studies were eligible for inclusion (Fig. 1). They included 
150 patients; 10 with a diagnosis of Crohn’s disease, 2 with 
indeterminate colitis and 138 with ulcerative colitis (UC).
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Study characteristics and quality assessment
One of the 8 studies was a case report, 4 were case studies, and 
3 were retrospective case-matched reviews comparing robotic 
to laparoscopic surgery in 2 studies and to open surgery in 1 
study [16–23]. Quality assessment is recorded in Table 1.
Type of procedure performed
The type of procedure performed in each of the studies varied 
as well as the extent of robotic involvement (Table 1). The 
most extensive involvement of the robotic system was used 
by Roviello et al. [23] in 4 patients involving a single-docking 
robotic proctocolectomy with formation of a terminal ileos-
tomy. A conventional laparoscopic port was also used during 
these procedures, principally to assist with additional traction. 
The remaining studies performed robotic proctectomy with or 
without variable amounts of laparoscopic assistance ± lapa-
roscopic colectomy ± extracorporeal formation of a J-pouch 
with formation of a hand-sewn/stapled (open or laparoscopic) 
ileal pouch-anal anastomosis (IPAA) via a perineal/Pfannen-
stiel/suprapubic incision ± diverting loop ileostomy (Table 1). 
Further classification regarding the exact type of procedure for 
each patient was not recorded in every study [16].
Primary outcomes
Mortality
There was no mortality in any of the studies.
Postoperative complications
Complications occurred in 81 patients (54%) including 
serious complications (Clavien-Dindo grade III–IV) in 30 
patients (20%). Early postoperative morbidity varied from 
0 to 100% (Table 2). 100% of the high-risk patients operated 
Fig. 1  Diagrammatic illustra-
tion of search strategy
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on with fulminant UC by McLemore et al. [18] experienced 
early complications, although all complications were a 
maximum of Clavien-Dindo II. The single case report did 
not describe any complications [20]. The remaining studies 
reported a morbidity rate of 40–75%. Rencuzogullari et al. 
[22] reported no statistically significant difference between 
postoperative complications following robotic and laparo-
scopic approaches, with similar postoperative outcomes 
reported in the second case-matched study (although no p 
value was obtained) [19]. The single case-matched retro-
spective study comparing robotic to open proctectomy also 
reported no statistically significant differences in postop-
erative complications between the two groups [17]. In this 
study, 10% of the patients undergoing robotic surgery under-
went a reoperation, which was statistically similar to the 5% 
in the control group (p = 0.18).
Secondary outcomes
Readmission rates
Overall, 37 patients (24.7%) were readmitted. Mark-Chris-
tensen et al. [17] reported a readmission rate of 40%, which 
is a significantly higher rate than that seen in the open sur-
gery group (p = 0.02 on univariate analysis and p = 0.03 on 
multivariate analysis). Rencuzogullari et al. [22] reported no 
significant difference in readmission rate between the robotic 
and laparoscopic group (p = 1.0).
Length of stay (LOS)
Overall, the mean LOS for 146 patients was 8.6 days, rang-
ing from 5.3 ± 1.2 to 15 days (Table 1). The 4 patients in the 
study by Roviello et al. [23] were excluded as only a median 
LOS was reported. Mark-Christensen et al. [17] reported a 
mean LOS of 9.1 ± 5 days following robotic surgery which 
was significantly shorter than the 11 ± 6.4 days following 
open surgery (p = 0.02), however in multivariate regression 
analysis taking into account the primary operation, body 
mass index, American Society of Anaesthesiologists clas-
sification, sex and age this finding was no longer signifi-
cant (p = 0.07). Rencuzogullari et al. [22] reported a mean 
LOS of 7.9 ± 6.4 days which was not statistically signifi-
cant from their laparoscopic group (p = 0.39). Miller et al. 
[19] also reported no significant difference in mean LOS 
between colectomised patients who underwent robotic proc-
tectomy (RP) + IPAA (RP–IPAA) (8.5 ± 3.8 days) and those 
who underwent laparoscopic proctectomy (LP) + IPAA 
(LP–IPAA) (6.1 ± 2.2 days; p = 0.17); however, there was 
a significantly longer mean LOS for robotic completion 
proctectomy (RP-CP) (6.4 ± 1.0 days) compared with lapa-
roscopic completion proctectomy (LP-CP) (4.1 ± 0.7 days; 
p = 0.02).
Conversion rates and estimated blood loss (EBL)
Overall, 11 robotic procedures were converted to open 
(7.3%). Six studies reported a conversion rate of zero, 
including analysis of 48 patients. The remaining 2 studies 
[17, 22] reported a conversion rate of 11.1 and 9.5%, respec-
tively. Reasons for conversion in reported by Rencuzogul-
lari et al. [22] included 1 case of extensive adhesions and 
1 case of unclear anatomy. There was no significant differ-
ence in conversion rate between robotic and laparoscopic 
approaches [22].
EBL was recorded in 6 studies (Table 1), involving 66 
patients, with a wide variation: 57.5–486 ml [19, 20]. Over-
all, mean (median of the means) EBL was 248.5 ml. Of note, 
Miller et al. [19] did not show a significant difference in EBL 
between RP-CP and LP-CP (p = 0.18), or between RP–IPAA 
and LP–IPAA (p = 0.15). However, Rencuzogullari et al. 
[22] reported a significantly higher EBL for the robotic com-
pared to laparoscopic approach (p = 0.002).
Procedure time
Direct comparison of the reported procedure time was dif-
ficult due to the heterogeneity of procedures between the 
studies (Table 1). Additionally, some studies only reported 
total operative time rather than a robotic time. However, the 
overall mean robotic operating time (median of the means) 
was 99 min out of a mean total operative time of 298.6 min.
McLemore et al. [18] reported a mean ± SD robotic 
time of 123 ± 14.9 min out of a total procedure time of 
436 ± 106.6 min. This total procedure time is notable, espe-
cially considering that all patients had previously undergone 
laparoscopic colectomy. However, this cohort underwent 
surgery for acute, severe disease with a diagnosis of fulmi-
nant UC. Roviello et al. [23] reported the shortest total pro-
cedure time 235 min and interestingly performed the most 
robotic surgery involving robotic colectomy in addition to 
proctectomy, although no anastomosis was performed.
Miller et  al. [19] directly compared total procedure 
time ± SD for colectomised patients undergoing RP-CP 
(351 ± 76.3 min) to LP-CP (238 ± 66.4 min), and there was a 
significant time increase with robotic procedures (p = 0.03). 
However, this difference was not significant for colecto-
mised patients undergoing RP–IPAA (370 ± 65.9 min) com-
pared to LP–IPAA (316 ± 78.4 min; p = 0.14). Rencuzog-
ullari et al. [22] reported a mean total operative time ± SD 
of 304 ± 109 min for robotic proctectomy ± laparoscopic 
colectomy ± IPAA which was significantly longer than the 
equivalent laparoscopic procedure (213 ± 86 min; p = 0.008). 
Finally, as would be expected, Mark-Christensen et al. [17] 
reported a significantly longer total operative time ± SD 
for robotic proctectomy ± laparoscopic colectomy + IPAA 
(284 ± 38 min) compared to the equivalent open procedure 
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(130 ± 38 min), which was significant in both univariate and 
multivariate analysis (p = <0.01).
Functional outcomes
The 3 case-matched studies reported similar long-term pouch 
outcomes between robotic and laparoscopic or open proce-
dures. Mark-Christensen et al. [17] reported 1 episode of pouch 
failure in the robotic group (p = 0.97), whilst Rencuzogullari 
et al. [22] reported 1 episode of pouch fistula (p > 0.99) and 1 
episode of anastomotic separation (p > 0.99). Miller et al. [19] 
reported similar functional outcomes between RP–IPAA and 
LP–IPAA after reversal of ileostomy. Although the numbers 
are small, there was no significant difference in pouch function 
and continence, specifically anal continence during daytime 
and night time (p = 0.58), minor leakage (p = 0.58), frequency 
of bowel movements (p = 0.15), ability to postpone bowel 
movements (p = 0.30) and anal pruritus (p = 0.14) between 
these cohorts. Post-procedure quality of life scores (p = 1.0), as 
well as sexual functional outcome measures including change 
in sexual desire (p = 0.66) and quality of erection (p = 1.0), 
were equivalent in the 2 groups [19].
Mean return of bowel function in days, following robotic 
proctectomy, was reported in 3 studies. Rencuzogullari 
et al. [22] reported a mean ± SD of 2.3 ± 1.5 days equiva-
lent to that seen in its laparoscopic group (p = 0.62). This 
length was comparable to mean return of bowel function 
reported by Miller et al. [19] for RP-CP (3.0 ± 0.8 days) 
and RP–IPAA (3.6 ± 2.8 days). Although return of bowel 
function following RP-CP took significantly longer than 
after LP-CP (p = 0.04), it was statistically equivalent for 
RP–IPAA and LP–IPAA (p  =  0.3). Pedraza et  al. [21] 
reported a mean ± SD of 2.4 ± 0.9 days to return of bowel 
function following robotic proctectomy +  laparoscopic 
colectomy + IPAA, which was broadly equivalent to the 
other 2 studies. Mean number of days to normal diet was 
reported in 2 studies. Pedraza et al. [21] reported a mean of 
2 ± 0.6 days which was comparable to that reported by Byrn 
et al. (4.7 ± 2.9 and 3.0 ± 0.6) [16].
Tertiary outcomes
Cost implications
Only 1 study reported a cost analysis [16]. Direct costs 
observed for robotic IBD cases, excluding cost of acqui-
sition, depreciation, amortisation and maintenance of the 
robotic platform, showed a decreasing trend over a period 
of 27  months ($19,278  ±  13,404 vs. $13,413  ±  2504; 
p = 0.06). The ratio of observed to expected cost, which 
aims to correct for patient-specific factors that increase 
cost outside of the surgical procedure, decreased over time 
(1.8 ± 0.8 vs. 1.2 ± 0.1; p = 0.02) perhaps as a result of 
decreased operating time and length of stay. No study com-
pared the cost of robotic surgery to traditional approaches.
Discussion
This systematic review identified 8 studies reporting out-
comes following robotic colorectal resection in 150 patients 
with IBD. Notably, there were no randomised trials; how-
ever, 2 retrospective studies showed comparable results 
between robotic and laparoscopic surgery and 1 between 
robotic and open surgery. The studies were heterogeneous 
in terms of the populations studied, procedures performed 
and criteria by which outcomes were measured, precluding 
formal meta-analysis.
Primary outcomes
The rate of reported pelvic sepsis, arguably the most signifi-
cant early complication following IPAA, in each of the stud-
ies analysed in this review fell within the range reported fol-
lowing IPAA in a meta-analysis of 43 observational studies 
(range 2.3–26.7%) [24]. However, the overall morbidity rate 
of 54% is higher than recent published literature evaluating 
laparoscopic surgery for IBD (Table 3) [25–34]. Although 
most studies defined the morbidity rate as the number of 
patients affected by complications [18, 20, 21, 23, 25–29, 31, 
32, 34], several studies, particularly those in this review [16, 
19, 22], did not specify how many patients were affected.
There was no significant difference in early postoperative 
complications between robotic and open surgery following 
IPPA [17], largely consistent with early meta-analyses of 
laparoscopic versus open studies during the ascending phase 
of the laparoscopic learning curve which reported, aside 
from a lower incidence of wound infection in laparoscopic 
surgery [35], equivalent adverse event rates between the 2 
groups [35–37]. More recent studies indicate that laparo-
scopic surgery is associated with fewer early complications 
and lower rates of pelvic sepsis [39, 40] than open surgery 
[28, 33, 38]. However, the supplementary use of mini-lapa-
rotomies or Pfannenstiel incisions in robotic surgery is often 
necessary and may limit the benefits that have been seen in 
other minimally invasive surgical procedures. In the study by 
Mark-Christensen et al. [17], rectal stapling was performed 
using non-endoscopic staplers in one-third of the robotic 
cases, to ensure an adequate level and completeness of the 
stapling, emphasising an important technical challenge to 
this approach [17].
The case-matched robotic and laparoscopic studies [19, 
22] also showed comparable morbidity rates, although 1 
study did not analyse p values [19]. Studies evaluating the 
adoption of robotic technology for rectal cancer patients 
suggest 3 phases, with the first phase of learning achieved 
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within a range of 9–41 cases [41–43]. It is likely, therefore, 
that the surgeons in these case-matched studies were in their 
initial learning curve of robotic surgery, though masters in 
laparoscopy and yet, robotic surgery provided comparable 
outcomes [17, 22, 29]. The absence of randomised con-
trolled trials, however, makes any definitive conclusions 
difficult. Furthermore, the ROLARR trial has not shown 
any reduction in 30-day morbidity in robotic compared to 
laparoscopic rectal cancer resections [9].
Secondary outcomes
Overall secondary outcomes were consistent with published 
laparoscopic studies (Table 3) [25–34].
Robotic readmission rates were similar to rates reported 
in laparoscopic case-matched controls [19, 22] although 
higher than in open surgery [17]. Importantly, this was not 
reflected in a higher major complication rate on readmission, 
indicating that there may be a lower threshold to readmit 
trial patients undergoing minimally invasive surgery [17]. 
Of note, the period during which readmission was analysed 
was not always declared and as such may represent a source 
of bias.
LOS was statistically similar to case-matched laparo-
scopic and open studies [17, 22]. Miller et al. [19] proceeded 
with RP-CP, in order to establish and optimise robotic sur-
gical technique and to avoid affecting long-term functional 
outcomes associated with restorative procedures, which may 
go some way to explain the better results they achieved with 
RP–IPAA as they had accumulated more experience. This 
is supported by Byrn et al. [16] who reported a significant 
reduction in mean LOS following robotic proctectomy over 
a 2-year period (p = 0.03), suggesting that recovery after 
robotic surgery may be quicker when performed by expe-
rienced operators. Of note, temporal and spatial patterns in 
adherence to principles of fast-track surgery may represent a 
substantial source of bias; the paper with the largest number 
of patients collected data over a 10-year period, from 2004 
to 2014 [17].
Although there was no significant difference in conver-
sion rates between case-matched robotic and laparoscopic 
procedures [22], it is important to note that conversion rate 
is a subjective endpoint. Overall EBL was consistent with 
EBL in laparoscopic studies (Table 3).
Procedure time was significantly longer than the time 
reported for case-matched laparoscopic [22] and open 
procedures [17]; however, the overall operative time 
appears comparable to published laparoscopic literature 
(Table 3). Conceivably, the operative time may decrease 
with increasing experience as was seen in the study by 
Miller et al. [19] where later procedures (RP–IPAA) were 
not significantly longer than their laparoscopic equivalent. 
Additionally, Byrn et al. [16] and Mark-Christensen et al. 
[17] showed a trend towards a decrease in total procedure 
time for robotic procedures over the course of their studies, 
although it was not clear at what stage of the procedure the 
time was shortened and the improvement was not statisti-
cally significant. Newer platforms, or hybrid procedures 
involving laparoscopic with robotic techniques, may help 
to reduce the necessity of multiple docking and operative 
times [22].
The ultimate purpose of IPAA surgery is to ensure sat-
isfactory pouch function, which is an outcome that many 
papers did not assess. Heterogeneity of functional outcome 
measured makes comparison difficult; however, the case-
matched studies showed no difference in days to return of 
bowel function following robotic or laparoscopic IPAA 
[19, 22] or pouch failure rates [17, 22]. One study reported 
no differences in pouch function, quality of life and sexual 
function after robotic or laparoscopic procedures [19]. It is 
worthwhile noting that the majority of patients with IBD are 
young and therefore future studies should include functional, 
including sexual, data analysis.
Tertiary outcomes
The overall economic feasibility of robotic surgery for IBD 
was not determined, as only 1 study, without a control group, 
assessed the cost of robotic surgery [16]. Currently, it seems 
likely that high costs will prevent widespread adoption of 
robotic surgery in the near future, particularly without any 
evidence of improved outcomes.
Limitations
In addition to those limitations already discussed, the most 
important limitation of this review is the low-quality papers 
analysed, mainly observational, single-centre, single-
surgeon, retrospective, non-randomised designs with low 
patient numbers. Additionally, the analysed papers did not 
have subgroup analyses, which made comparing results for 
one specific operation or a specific disease (e.g. Crohn’s or 
UC) impossible. As such, patients with different diseases, 
preoperative conditions and operations were compared, lead-
ing to bias when comparing postoperative outcome. Finally, 
analysing articles in the English language only has limited 
the coverage of the review.
Conclusions
Outcome data of robotic surgery for IBD must be inter-
preted with caution due to low-quality studies. However, 
robotic resections in patients with IBD are technically 
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feasible. The significantly higher overall costs necessitate 
evidence for advantages over traditional approaches. Thus 
far, no such advantages have been demonstrated preclud-
ing a recommendation for widespread adoption.
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